SE517528C2 - Datoriserad identifiering av normala och onormala dygnsmönster för kortisolutsöndring och testosteronnivåer från mänskliga salivprov - Google Patents

Datoriserad identifiering av normala och onormala dygnsmönster för kortisolutsöndring och testosteronnivåer från mänskliga salivprov

Info

Publication number: SE517528C2
Authority: SE; Sweden
Prior art keywords: cortisol; variable; computer; cort; logic
Prior art date: 2000-12-04

Application number

SE0004461A

Other languages

English (en)

Swedish (sv)

Other versions

SE0004461L (sv

SE0004461D0 (sv

Inventor

Peter Wanger

Lene Martin

Original Assignee

Diagno Internat Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-04

Filing date

2000-12-04

Publication date

2002-06-18

2000-12-04 Application filed by Diagno Internat Bv filed Critical Diagno Internat Bv

2000-12-04 Priority to SE0004461A priority Critical patent/SE517528C2/sv

2000-12-04 Publication of SE0004461D0 publication Critical patent/SE0004461D0/xx

2001-12-04 Priority to DE60130020T priority patent/DE60130020T2/de

2001-12-04 Priority to PCT/SE2001/002670 priority patent/WO2002046771A1/en

2001-12-04 Priority to JP2002548457A priority patent/JP2004515765A/ja

2001-12-04 Priority to AT01999819T priority patent/ATE370417T1/de

2001-12-04 Priority to EP01999819A priority patent/EP1340089B1/de

2002-06-05 Publication of SE0004461L publication Critical patent/SE0004461L/xx

2002-06-18 Publication of SE517528C2 publication Critical patent/SE517528C2/sv

2003-05-30 Priority to US10/448,379 priority patent/US7805396B2/en

Links

JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 title claims abstract description 114
MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 title claims abstract description 74
229960000890 hydrocortisone Drugs 0.000 title claims abstract description 58
229960003604 testosterone Drugs 0.000 title claims abstract description 37
210000003296 saliva Anatomy 0.000 title claims abstract description 25
230000002159 abnormal effect Effects 0.000 title claims abstract description 15
230000028327 secretion Effects 0.000 title claims abstract description 13
230000004179 hypothalamic–pituitary–adrenal axis Effects 0.000 claims abstract description 44
238000000034 method Methods 0.000 claims abstract description 18
238000004422 calculation algorithm Methods 0.000 claims abstract description 6
238000000338 in vitro Methods 0.000 claims abstract 2
238000012360 testing method Methods 0.000 claims description 44
230000006870 function Effects 0.000 claims description 23
238000011156 evaluation Methods 0.000 claims description 19
238000004590 computer program Methods 0.000 claims description 18
230000015654 memory Effects 0.000 claims description 9
230000036541 health Effects 0.000 claims description 5
230000008859 change Effects 0.000 claims description 3
230000004044 response Effects 0.000 claims description 3
230000000295 complement effect Effects 0.000 claims description 2
238000010340 saliva test Methods 0.000 claims description 2
241001550224 Apha Species 0.000 claims 1
230000002238 attenuated effect Effects 0.000 claims 1
230000002542 deteriorative effect Effects 0.000 claims 1
238000002955 isolation Methods 0.000 claims 1
238000005259 measurement Methods 0.000 description 24
238000004458 analytical method Methods 0.000 description 9
230000008901 benefit Effects 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
210000002966 serum Anatomy 0.000 description 4
208000024172 Cardiovascular disease Diseases 0.000 description 3
206010022489 Insulin Resistance Diseases 0.000 description 3
230000002060 circadian Effects 0.000 description 3
230000002354 daily effect Effects 0.000 description 3
229960003957 dexamethasone Drugs 0.000 description 3
UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
208000019622 heart disease Diseases 0.000 description 3
229940088597 hormone Drugs 0.000 description 3
239000005556 hormone Substances 0.000 description 3
230000002503 metabolic effect Effects 0.000 description 3
238000010998 test method Methods 0.000 description 3
208000001072 type 2 diabetes mellitus Diseases 0.000 description 3
230000005856 abnormality Effects 0.000 description 2
230000009471 action Effects 0.000 description 2
238000003556 assay Methods 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
238000004364 calculation method Methods 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
201000010099 disease Diseases 0.000 description 2
230000000694 effects Effects 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
238000012552 review Methods 0.000 description 2
238000007619 statistical method Methods 0.000 description 2
230000003936 working memory Effects 0.000 description 2
208000004611 Abdominal Obesity Diseases 0.000 description 1
235000011297 Brassica napobrassica Nutrition 0.000 description 1
206010065941 Central obesity Diseases 0.000 description 1
241000282412 Homo Species 0.000 description 1
208000001145 Metabolic Syndrome Diseases 0.000 description 1
241000473945 Theria <moth genus> Species 0.000 description 1
201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
210000004404 adrenal cortex Anatomy 0.000 description 1
210000004100 adrenal gland Anatomy 0.000 description 1
238000010171 animal model Methods 0.000 description 1
238000013459 approach Methods 0.000 description 1
230000006399 behavior Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
JQQZVABVKIDEFR-UHFFFAOYSA-J bumadizone calcium hemihydrate Chemical compound O.[Ca+2].[Ca+2].C=1C=CC=CC=1N(C(=O)C(C([O-])=O)CCCC)NC1=CC=CC=C1.C=1C=CC=CC=1N(C(=O)C(C([O-])=O)CCCC)NC1=CC=CC=C1.C=1C=CC=CC=1N(C(=O)C(C([O-])=O)CCCC)NC1=CC=CC=C1.C=1C=CC=CC=1N(C(=O)C(C([O-])=O)CCCC)NC1=CC=CC=C1 JQQZVABVKIDEFR-UHFFFAOYSA-J 0.000 description 1
230000027288 circadian rhythm Effects 0.000 description 1
238000004891 communication Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
230000029142 excretion Effects 0.000 description 1
230000004720 fertilization Effects 0.000 description 1
235000013305 food Nutrition 0.000 description 1
238000010230 functional analysis Methods 0.000 description 1
239000008103 glucose Substances 0.000 description 1
210000002149 gonad Anatomy 0.000 description 1
239000003163 gonadal steroid hormone Substances 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 1
238000013507 mapping Methods 0.000 description 1
230000006371 metabolic abnormality Effects 0.000 description 1
208000030159 metabolic disease Diseases 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000000955 neuroendocrine Effects 0.000 description 1
238000009806 oophorectomy Methods 0.000 description 1
238000012545 processing Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
206010039073 rheumatoid arthritis Diseases 0.000 description 1
230000036299 sexual function Effects 0.000 description 1
239000008279 sol Substances 0.000 description 1
230000003068 static effect Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
210000001550 testis Anatomy 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
230000036642 wellbeing Effects 0.000 description 1
239000002023 wood Substances 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Physics & Mathematics (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Endocrinology (AREA)
Microbiology (AREA)
Pathology (AREA)
Epidemiology (AREA)
Medical Informatics (AREA)
Primary Health Care (AREA)
Public Health (AREA)
Investigating Or Analysing Biological Materials (AREA)
Eye Examination Apparatus (AREA)
Measuring And Recording Apparatus For Diagnosis (AREA)

SE0004461A 2000-12-04 2000-12-04 Datoriserad identifiering av normala och onormala dygnsmönster för kortisolutsöndring och testosteronnivåer från mänskliga salivprov SE517528C2 (sv)

Priority Applications (7)

Application Number	Priority Date	Filing Date	Title
SE0004461A SE517528C2 (sv)	2000-12-04	2000-12-04	Datoriserad identifiering av normala och onormala dygnsmönster för kortisolutsöndring och testosteronnivåer från mänskliga salivprov
DE60130020T DE60130020T2 (de)	2000-12-04	2001-12-04	Computerisierte identifizierung normaler und abnormaler diurnaler cortisolsekretionsmuster und von testosteronspiegeln aus menschlichen speichelproben
PCT/SE2001/002670 WO2002046771A1 (en)	2000-12-04	2001-12-04	Computerized identification of normal and abnormal diurnal cortisol secretion patterns and levels of testosterone from human saliva samples
JP2002548457A JP2004515765A (ja)	2000-12-04	2001-12-04	人間の唾液標本からの一日の正常および異常コルチゾール分泌パターンとテストステロン水準のコンピュータ化識別
AT01999819T ATE370417T1 (de)	2000-12-04	2001-12-04	Computerisierte identifizierung normaler und abnormaler diurnaler cortisolsekretionsmuster und von testosteronspiegeln aus menschlichen speichelproben
EP01999819A EP1340089B1 (de)	2000-12-04	2001-12-04	Computerisierte identifizierung normaler und abnormaler diurnaler cortisolsekretionsmuster und von testosteronspiegeln aus menschlichen speichelproben
US10/448,379 US7805396B2 (en)	2000-12-04	2003-05-30	Computerized identification of normal and abnormal diurnal cortisol secretion patterns and levels of testosterone from human saliva samples

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE0004461A SE517528C2 (sv)	2000-12-04	2000-12-04	Datoriserad identifiering av normala och onormala dygnsmönster för kortisolutsöndring och testosteronnivåer från mänskliga salivprov

Publications (3)

Publication Number	Publication Date
SE0004461D0 SE0004461D0 (sv)	2000-12-04
SE0004461L SE0004461L (sv)	2002-06-05
SE517528C2 true SE517528C2 (sv)	2002-06-18

Family

ID=20282077

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE0004461A SE517528C2 (sv)	2000-12-04	2000-12-04	Datoriserad identifiering av normala och onormala dygnsmönster för kortisolutsöndring och testosteronnivåer från mänskliga salivprov

Country Status (7)

Country	Link
US (1)	US7805396B2 (de)
EP (1)	EP1340089B1 (de)
JP (1)	JP2004515765A (de)
AT (1)	ATE370417T1 (de)
DE (1)	DE60130020T2 (de)
SE (1)	SE517528C2 (de)
WO (1)	WO2002046771A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060129590A1 (en) *	2004-12-10	2006-06-15	Aoki-Rice Companies	Method and medium for managing data
AU2008251588B2 (en)	2007-05-10	2013-10-31	Advanced Breath Diagnostics, Llc	Methods and systems for assessing gastric emptying
KR101029251B1 (ko)	2009-06-18	2011-04-18	전남대학교산학협력단	타액내 코티졸 측정을 통한 코티졸의 일주기리듬 평가 지표 및 방법
US11195057B2 (en)	2014-03-18	2021-12-07	Z Advanced Computing, Inc.	System and method for extremely efficient image and pattern recognition and artificial intelligence platform
US9916538B2 (en)	2012-09-15	2018-03-13	Z Advanced Computing, Inc.	Method and system for feature detection
US11914674B2 (en)	2011-09-24	2024-02-27	Z Advanced Computing, Inc.	System and method for extremely efficient image and pattern recognition and artificial intelligence platform
US11074495B2 (en)	2013-02-28	2021-07-27	Z Advanced Computing, Inc. (Zac)	System and method for extremely efficient image and pattern recognition and artificial intelligence platform
US8311973B1 (en)	2011-09-24	2012-11-13	Zadeh Lotfi A	Methods and systems for applications for Z-numbers
US8873813B2 (en)	2012-09-17	2014-10-28	Z Advanced Computing, Inc.	Application of Z-webs and Z-factors to analytics, search engine, learning, recognition, natural language, and other utilities
KR101444235B1 (ko) *	2012-07-17	2014-09-26	주식회사 피코팜	뇌하수체 부신축 기능의 상관관계를 이용하는 ｃｒｐｓ―１ 질환 진단 방법
US10772534B2 (en)	2013-03-13	2020-09-15	Advanced Breath Diagnostics, Llc	Single-point gastric emptying breath tests
KR102404986B1 (ko) *	2022-01-20	2022-06-07	(주) 마인즈에이아이	남성 갱년기 진단을 위한 정보를 제공하는 방법 및 이의 용도

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5788640A (en) *	1995-10-26	1998-08-04	Peters; Robert Mitchell	System and method for performing fuzzy cluster classification of stress tests
EP1027459A1 (de) *	1997-07-14	2000-08-16	Abbott Laboratories	Telemedizin
JPH1138004A (ja) *	1997-07-16	1999-02-12	Pola Chem Ind Inc	ストレスの定量法
JP3108765B2 (ja) *	1999-03-24	2000-11-13	工業技術院長	慢性ストレス判定方法及びその装置、記録媒体、判定シート

2000
- 2000-12-04 SE SE0004461A patent/SE517528C2/sv not_active IP Right Cessation
2001
- 2001-12-04 DE DE60130020T patent/DE60130020T2/de not_active Expired - Lifetime
- 2001-12-04 WO PCT/SE2001/002670 patent/WO2002046771A1/en not_active Ceased
- 2001-12-04 EP EP01999819A patent/EP1340089B1/de not_active Expired - Lifetime
- 2001-12-04 JP JP2002548457A patent/JP2004515765A/ja active Pending
- 2001-12-04 AT AT01999819T patent/ATE370417T1/de not_active IP Right Cessation
2003
- 2003-05-30 US US10/448,379 patent/US7805396B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE60130020T2 (de)	2008-05-08
EP1340089A1 (de)	2003-09-03
US20100241606A9 (en)	2010-09-23
US7805396B2 (en)	2010-09-28
SE0004461L (sv)	2002-06-05
EP1340089B1 (de)	2007-08-15
ATE370417T1 (de)	2007-09-15
SE0004461D0 (sv)	2000-12-04
WO2002046771A1 (en)	2002-06-13
JP2004515765A (ja)	2004-05-27
DE60130020D1 (de)	2007-09-27
US20040039719A1 (en)	2004-02-26

Legal Events

Date	Code	Title	Description
2016-08-02	NUG	Patent has lapsed

Publication	Publication Date	Title
Grosvenor et al.	2024	Autism diagnosis among US children and adults, 2011-2022
Young et al.	2019	Reliability, construct validity, and responsiveness of the neck disability index and numeric pain rating scale in patients with mechanical neck pain without upper extremity symptoms
Fritz et al.	2017	Handgrip strength as a means of monitoring progression of cognitive decline–a scoping review
Tengs et al.	2002	A meta-analysis of utility estimates for HIV/AIDS
Scheidt-Nave et al.	2012	German health interview and examination survey for adults (DEGS)-design, objectives and implementation of the first data collection wave
Minet et al.	2010	Mediating the effect of self-care management intervention in type 2 diabetes: a meta-analysis of 47 randomised controlled trials
US20120101846A1 (en)	2012-04-26	Computer-Implemented Method For Displaying Patient-Related Diagnoses Of Chronic Illnesses
US8548827B2 (en)	2013-10-01	Computer-implemented method for medical diagnosis support
JP5317496B2 (ja)	2013-10-16	健康疾患管理支援装置及び方法、並びに医用ネットワークシステム
Widyana et al.	2020	Psychometric properties of internet-administered version of depression, anxiety and stress scales (DASS-42) in sample Indonesian adult
US7805396B2 (en)	2010-09-28	Computerized identification of normal and abnormal diurnal cortisol secretion patterns and levels of testosterone from human saliva samples
de Souza de Silva et al.	2019	Association between cardiorespiratory fitness, obesity, and health care costs: the veterans exercise testing study
Hjelholt et al.	2022	The interaction effect between previous stroke and hip fracture on postoperative mortality: a nationwide cohort study
Krops et al.	2018	Reliability of translation of the RAND 36-item health survey in a post-rehabilitation population
Sundaram et al.	2009	Health-related quality of life and quality of life in type 2 diabetes: relationships in a cross-sectional study
Deo et al.	2005	Design and development of a web-based application for diabetes patient data management
Yang et al.	2025	Heterogeneity of Fatigue in Patients with Chronic Heart Failure: Latent Categories and Influencing Factors
Yarris et al.	2012	How accurately can emergency department providers estimate patient satisfaction?
US10973467B2 (en)	2021-04-13	Method and system for automated diagnostics of none-infectious illnesses
Yen et al.	2014	A nationwide population cohort study: irritable bowel syndrome is a risk factor of osteoporosis
Duan et al.	2021	A scoping review of cross-sectional studies on traditional Chinese medicine
Joshi et al.	2011	Quality of nutrition related information on the internet for osteoporosis patients: a critical review
Berlowitz et al.	1995	Ambulatory care casemix measures
Marshall	2006	Estimating the value of information in strategies for identifying patients at high risk of cardiovascular disease
Miao et al.	2024	Sedentary behavior from television watching elevates GlycA levels: a bidirectional Mendelian randomization study